The Noncanonical Role of Hippo Signaling in Cancer
Authors:
- 2 April 2026
- journal article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Biology
- Vol. 18 (10)
Abstract
Originally discovered in Drosophila, the Hippo pathway has emerged as an evolutionarily conserved signaling pathway that controls tissue growth and organ size in species ranging from insects to human. Unsurprisingly, dysregulation of Hippo pathway activity has been implicated in a broad spectrum of human cancers. While the prevailing view holds that the Hippo pathway suppresses tumor growth by inhibiting the oncogenic activity of the pathway effector Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ), recent studies have uncovered context-dependent tumor suppressor function of YAP/TAZ in several cancer types, including hematological malignancies, estrogen receptor (ER)-positive breast cancer, androgen receptor (AR)-positive prostate cancer, and Von Hippel-Lindau-deficient clear cell renal cell carcinoma (ccRCC). In this review, we explore the unconventional tumor-suppressive function of YAP/TAZ and the mechanisms through which they inhibit tumor growth, with an emphasis on recent findings in hormone-regulated cancers and ccRCC. Finally, we discuss the therapeutic implications of these emerging findings for cancer treatment.Keywords
This publication has 192 references indexed in Scilit:
- Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAPAdvanced Science, 2025
- Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityCancer Cell, 2021
- Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric CancerCancer Cell, 2020
- SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes TumorigenesisCancer Cell, 2018
- WW and C2 domain–containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathwayHepatology, 2018
- Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZHepatology, 2016
- YAP/TAZ at the Roots of CancerCancer Cell, 2016
- Intestinal stem cell response to injury: lessons from DrosophilaCellular and Molecular Life Sciences, 2016
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- Androgen Deprivation Therapy for Prostate CancerJAMA, 2005